Catalio Capital Management Revenue and Competitors

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • Catalio Capital Management's estimated annual revenue is currently $7.6M per year.(i)
  • Catalio Capital Management's estimated revenue per employee is $181,600

Employee Data

  • Catalio Capital Management has 42 Employees.(i)
  • Catalio Capital Management grew their employee count by 0% last year.

Catalio Capital Management's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VP – North AmericaReveal Email/Phone
3
Head ImpactReveal Email/Phone
4
VPReveal Email/Phone
5
VP, EuropeReveal Email/Phone
6
General CounselReveal Email/Phone
7
Head FinanceReveal Email/Phone
8
Head ResearchReveal Email/Phone
9
Head European & Middle Eastern Institutional SalesReveal Email/Phone
10
Head Investor ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M408%N/AN/A
#2
$38.8M15911%N/AN/A
#3
$58.2M2335%N/AN/A
#4
$37.1M152-7%N/AN/A
#5
$3.5M220%N/AN/A
#6
$6.5M36-3%N/AN/A
#7
$17.9M798%N/AN/A
#8
$282.4M8700%N/AN/A
#9
$6M205%$73MN/A
#10
$46.2M1852%N/AN/A
Add Company

What Is Catalio Capital Management?

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

keywords:N/A

N/A

Total Funding

42

Number of Employees

$7.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Catalio Capital Management News

2022-04-17 - Octant Raises $80 Million Series B Round to Support ...

... today announced an $80 million Series B financing round led by Catalio Capital Management (“Catalio”), established a Deep Mutational...

2022-04-17 - Octant raises $80m in Series B round led by Catalio Capital ...

... medicines for complex diseases, has raised $80 million in a Series B financing round led by Catalio Capital Management (Catalio).

2022-04-17 - Synthetic biology firm Octant closes $80M funding, nabs new ...

It's clearly convinced Catalio Capital Management, a firm with five successful IPOs to its name since it was founded in 2020. Catalio led Octant's series B...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M428%N/A
#2
$3.4M420%N/A
#3
$4.9M420%N/A
#4
$8.6M42-11%$15M
#5
$7.5M420%N/A